<DOC>
	<DOC>NCT01514578</DOC>
	<brief_summary>This study will evaluate the safety, blood levels, and effects of TRV130A on pain perception and sedation in healthy adult males.</brief_summary>
	<brief_title>Single Ascending Dose Study of Intravenous TRV130A in Healthy Adult Males</brief_title>
	<detailed_description />
	<criteria>Healthy adult male 19 50 years of age Body weight &gt;/= 50 kg Capable of giving written informed consent Clinically significant disease or conditions that may place the subject at unacceptable risk as a participant in the study, or that may interfere with the safety, tolerability or pharmacodynamic evaluations in the study Laboratory tests positive for HIV, Hepatitis B virus surface antigen, or Hepatitis C virus antibody; elevations of aspartate aminotransferase or alanine aminotransferase; positive drug or alcohol test; positive urine test for cotinine Major surgery within 4 weeks of screening</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>TRV130A</keyword>
</DOC>